Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: A matched case-control study-Reference-Cited by-同舟云学术

Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: A matched case-control study

Published:2014-06 Issue:6 Volume:42 Page:621-625
ISSN:0196-6553
Container-title:American Journal of Infection Control
language:en
Short-container-title:American Journal of Infection Control

Author:

Ahn Jin Young,Song Je Eun,Kim Min Hyung,Choi Heun,Kim Jae Kyung,Ann Hea Won,Kim Jung Ho^ORCID,Jeon Yongduk,Jeong Su Jin,Kim Sun Bean^ORCID,Ku Nam Su,Han Sang Hoon,Song Young Goo,Yong Dongeun,Lee Kyungwon,Kim June Myung^ORCID,Choi Jun Yong

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Health Policy,Epidemiology

Reference32 articles.

1. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48–like carbapenemases and outer membrane protein loss;Gulmez;Int J Antimicrob Agents,2008

2. Escherichia coli: development of carbapenem resistance during therapy;Hong;Clin Infect Dis,2005

3. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008);Rhomberg;Diagn Microbiol Infect Dis,2009

4. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study;Falagas;J Antimicrob Chemother,2007

5. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients;Kwak;Microb Drug Resist,2005

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The correlation between intestinal colonization and infection of carbapenem-resistant Klebsiella pneumoniae: A systematic review;Journal of Global Antimicrobial Resistance;2024-09

2. Auranofin enhances the antibacterial effects of ertapenem against carbapenem-resistant Escherichia coli;Diagnostic Microbiology and Infectious Disease;2024-09

3. Clinical risk factors and outcomes of carbapenem-resistant Escherichia coli nosocomial infections in a Chinese teaching hospital: a retrospective study from 2013 to 2020;Microbiology Spectrum;2024-07-02

4. Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching;Journal of Korean Medical Science;2024

5. Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli;Antimicrobial Agents and Chemotherapy;2023-10-18